Literature Citations
1. Green Synthesis of Selenium Nanoparticles Using Rosmarinus officinalis and Investigated their Antimicrobial Activity. Adibian, F., R.S. Ghaderi, Z. Sabouri, J. Davoodi, M. Kazemi, K. Ghazvini, M. Youssefi, S. Soleimanpour, and M. Darroudi. Biometals, 2022. 35(1): p. 147-158. PMID[35018556].
[PubMed]. TB_02_2022.
2. Study of Antimycobacterial, Cytotoxic, and Mutagenic Potential of Polymeric Nanoparticles of Copper (II) Complex. Aleixo, N.A., P. Gomes, P.B.D. Silva, M.R. Sato, D.L. Campos, H.D.S. Barud, G.R. Castro, G.A. Islan, C. Toledo, F. Karp, M. Chorilli, F.R. Pavan, and F.A. Resende. Journal of Microencapsulation, 2022. 39(1): p. 61-71. PMID[34984941].
[PubMed]. TB_02_2022.
3. Synthesis and Critical View on the Structure-activity Relationships of N-(Substituted phenyl)-/N-diPhenylmethyl-piperazine-based Conjugates as Antimycobacterial Agents. Curillova, J., M. Pechacova, T. Padrtova, D. Pecher, S. Mascaretti, J. Jampilek, L. Paskova, F. Bilka, G. Kovac, and I. Malik. Applied Sciences, 2022. 12(1): 300. ISI[000752599900001].
[WOS]. TB_02_2022.
4. Microwave-assisted Organic Synthesis, Antimycobacterial Activity, Structure-activity Relationship and Molecular Docking Studies of Some Novel Indole-oxadiazole Hybrids. Desai, N.C., H.C. Somani, H.K. Mehta, D.J. Jadeja, A.G. Khasiya, and V.M. Khedkar. SAR and QSAR in Environmental Research, 2022. 33(2): p. 89-109. PMID[35102805].
[PubMed]. TB_02_2022.
5. The Veterinary Anti-parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis Dpre1 Enzyme. Ezquerra-Aznárez, J.M., G. Degiacomi, H. Gašparovič, G. Stelitano, J.C. Sammartino, J. Korduláková, P. Governa, F. Manetti, M.R. Pasca, L.R. Chiarelli, and S. Ramón-García. International Journal of Molecular Sciences, 2022. 23(2). PMID [35054958]. PMCID[PMC8776228].
[PubMed]. TB_02_2022.
6. Kimidinomycin, a New Antibiotic against Mycobacterium avium Complex, Produced by Streptomyces sp. KKTA-0263. Hikima, A., S. Asamizu, H. Onaka, H. Zhang, H. Tomoda, and N. Koyama. The Journal of Antibiotics, 2022. 75(2): p. 72-76. PMID[34949834].
[PubMed]. TB_02_2022.
7. Novel Antimicrobial 8-Hydroxyquinoline-based Agents: Current Development, Structure-activity Relationships, and Perspectives. Joaquim, A.R., M.P. Gionbelli, G. Gosmann, A.M. Fuentefria, M.S. Lopes, and S. Fernandes de Andrade. Journal of Medicinal Chemistry, 2021. 64(22): p. 16349-16379. PMID[34779640].
[PubMed]. TB_02_2022.
8. Synthesis and Biological Evaluation of Isatin oxime ether-tethered aryl 1H-1,2,3-triazoles as Inhibitors of Mycobacterium tuberculosis. Kancharla, S.K., S. Birudaraju, A. Pal, L.K. Reddy, E.R. Reddy, S.K. Vagolu, D. Sriram, K.B. Bonige, and R.B. Korupolu. New Journal of Chemistry, 2022. 46(6): p. 2863-2874. ISI[000745100500001].
[WOS]. TB_02_2022.
9. Design, Synthesis and Anti-mycobacterial Evaluation of Imidazo[1,2-a]pyridine Analogues. Khetmalis, Y.M., S. Chitti, A.U. Wunnava, B.K. Kumar, M.M.K. Kumar, S. Murugesan, and K. Sekhar. RSC Medicinal Chemistry, 2022. ISI[000749685700001].
[WOS]. TB_02_2022.
10. Synthesis, Pharmacokinetic and Molecular Docking Studies of New Benzohydrazide Derivatives Possessing Anti-tubercular Activity against Mycobacterium tuberculosis H(37)Rv. Lalavani, N.H., H.R. Gandhi, K.A. Bhensdadia, R.K. Patel, and S.H. Baluja. Journal of Molecular Structure, 2022. 1250(3); 131884. ISI[000744683300012].
[WOS]. TB_02_2022.
11. Design, Synthesis, Biological Screening and Molecular Docking Studies of Novel Multifunctional 1,4-di (Aryl/Heteroaryl) substituted piperazine Derivatives as Potential Antitubercular and Antimicrobial Agents. Mekonnen Sanka, B., D. Mamo Tadesse, E. Teju Bedada, E.T. Mengesha, and G.N. Babu. Bioorganic Chemistry, 2022. 119: 105568. PMID[34968884].
[PubMed]. TB_02_2022.
12. In Vitro and in Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas. Ottavi, S., S.M. Scarry, J. Mosior, Y. Ling, J. Roberts, A. Singh, D. Zhang, L. Goullieux, C. Roubert, E. Bacqué, H.R. Lagiakos, J. Vendome, F. Moraca, K. Li, A.J. Perkowski, R. Ramesh, M.M. Bowler, W. Tracy, V.A. Feher, J.C. Sacchettini, B.S. Gold, C.F. Nathan, and J. Aubé. Journal of Medicinal Chemistry, 2022. 65(3): p. 1996-2022. PMID[35044775]. PMCID[PMC8842310].
[PubMed]. TB_02_2022.
13. 1H-1,2,3-Triazole Embedded Isatin-benzaldehyde-bis(heteronuclearhydrazones): Design, Synthesis, Antimycobacterial, and Cytotoxic Evaluation. Sharma, B., S. Kumar, Preeti, M.D. Johansen, L. Kremer, and V. Kumar. Chemical Biology & Drug Design, 2022. 99(2): p. 301-307. PMID[34786862].
[PubMed]. TB_02_2022.
14. Synthesis and Structure-activity Relationships for a New Class of Tetrahydronaphthalene amide Inhibitors of Mycobacterium tuberculosis. Sutherland, H.S., G.L. Lu, A.S.T. Tong, D. Conole, S.G. Franzblau, A.M. Upton, M.U. Lotlikar, C.B. Cooper, B.D. Palmer, P.J. Choi, and W.A. Denny. European Journal of Medicinal Chemistry, 2022. 229: 114059. PMID[34963068]. PMCID[PMC8811485].
[PubMed]. TB_02_2022.
Patent Citations
This month, no relevant Mycobacterium spp. patents were identified.